Blood Res  
EBV reactivation mimicking a lymphoproliferative disorder associated with ruxolitinib therapy for myelofibrosis
Shruti Prem1, David Loach1, Jeffrey Lipton1, Rajat Kumar1, Vikas Gupta2
1Division of Allo-BMT, 2Division of Leukemia, Princess Margaret Centre, Toronto, Ontario
Correspondence to: Vikas Gupta, M.D.
Division of Leukemia, DMOH, Princess Margaret Centre, Toronto, Ontario M5G2M9, Canada
E-mail : vikas.gupta@uhn.ca
Published online: November 5, 2019.
© The Korean Journal of Hematology. All rights reserved.



e-submission

This Article

Current Issue

ba_link01

Indexed/Covered by

Today : 51  /
Total : 164,879